𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination of Chemotherapy and Monoclonal Antibodies for the Treatment of Lymphoma

✍ Scribed by Catherine Thieblemont; Bertrand Coiffier


Publisher
Carden Jennings Publishing
Year
2002
Tongue
English
Weight
175 KB
Volume
76
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Synergistic cytotoxicity of iodine-131-a
✍ Timothy A. Johnson; Oliver W. Press πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 231 KB

Preliminary clinical trials suggest that iodine-131 ( 131 I)labeled anti-CD20 monoclonal antibodies (MAbs) are effective single agents for the treatment of relapsed non-Hodgkin's B-cell lymphomas. However, despite high initial response rates, most patients treated in this manner will eventually rela

Combination chemotherapy of non-Hodgkin
✍ Forcier, R. Jackson ;McLntyre, O. Ross ;Nissen, Nis I. ;Pajak, Thomas F. ;Glidew πŸ“‚ Article πŸ“… 1978 πŸ› John Wiley and Sons 🌐 English βš– 574 KB

## Abstract A randomized therapeutic trial of three induction regimens for patients with lymphosarcoma and reticulum‐cell sarcoma was conducted by the Cancer and Leukemia Group B (CALGB) (formerly Acute Leukemia Group B). Addition of streptonigrin, but not cyclophosphamide, to the combination of vi

Treatment of Burkitt's lymphoma: Randomi
✍ Charles L. M. Olweny; Edward Katongole-Mbidde; Albert Kaddu-Mukasa; Isaac Atine; πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 374 KB

## Abstract A randomized clinical trial designed to compare the effectiveness of cytoxan (CTX) alone versus a combination consisting of CTX, vincristine (Oncovin) and methotrexate (COM) in the treatment of Burkitt's lymphoma (BL) was carried out. Nineteen patients were selected at random to receive